Richard J. Knox

3.8k total citations
64 papers, 3.1k citations indexed

About

Richard J. Knox is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Richard J. Knox has authored 64 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 27 papers in Organic Chemistry and 14 papers in Toxicology. Recurrent topics in Richard J. Knox's work include Bioactive Compounds and Antitumor Agents (14 papers), Cancer therapeutics and mechanisms (14 papers) and Biochemical and Molecular Research (13 papers). Richard J. Knox is often cited by papers focused on Bioactive Compounds and Antitumor Agents (14 papers), Cancer therapeutics and mechanisms (14 papers) and Biochemical and Molecular Research (13 papers). Richard J. Knox collaborates with scholars based in United Kingdom, United States and Slovakia. Richard J. Knox's co-authors include Frank Friedlos, J. J. Roberts, David Lydall, Roger G. Melton, Marion P. Boland, Shiuan Chen, Kebin Wu, Philip J. Burke, Roger F. Sherwood and Brian Coles and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Personality and Social Psychology.

In The Last Decade

Richard J. Knox

63 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Knox United Kingdom 33 1.8k 924 641 449 421 64 3.1k
Frank Friedlos United Kingdom 30 2.2k 1.2× 688 0.7× 942 1.5× 566 1.3× 602 1.4× 59 3.2k
Mary K. Danks United States 39 3.4k 1.9× 503 0.5× 2.0k 3.1× 191 0.4× 420 1.0× 99 5.0k
Athanassios Giannis Germany 43 4.0k 2.2× 3.0k 3.2× 818 1.3× 342 0.8× 156 0.4× 196 6.7k
Roger M. Phillips United Kingdom 38 2.1k 1.1× 1.7k 1.8× 1.4k 2.2× 199 0.4× 185 0.4× 162 4.9k
Jeffrey A. Dodge United States 31 1.4k 0.8× 1.1k 1.2× 364 0.6× 102 0.2× 842 2.0× 68 3.4k
Hirofumi Nakano Japan 26 1.6k 0.9× 434 0.5× 637 1.0× 101 0.2× 128 0.3× 140 3.1k
Rosanna Supino Italy 37 3.0k 1.7× 593 0.6× 1.7k 2.7× 128 0.3× 165 0.4× 109 4.9k
Ze‐Hong Miao China 37 2.7k 1.5× 888 1.0× 968 1.5× 373 0.8× 102 0.2× 136 4.3k
Graham J. Atwell New Zealand 35 2.4k 1.3× 1.8k 1.9× 676 1.1× 148 0.3× 70 0.2× 111 3.8k
Birandra K. Sinha United States 38 3.2k 1.8× 953 1.0× 1.9k 3.0× 65 0.1× 234 0.6× 142 5.3k

Countries citing papers authored by Richard J. Knox

Since Specialization
Citations

This map shows the geographic impact of Richard J. Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Knox more than expected).

Fields of papers citing papers by Richard J. Knox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Knox. The network helps show where Richard J. Knox may publish in the future.

Co-authorship network of co-authors of Richard J. Knox

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Knox. A scholar is included among the top collaborators of Richard J. Knox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Knox. Richard J. Knox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biggerstaff, Deborah, et al.. (2018). Phronesis in medical decision making:medical leadership, virtue ethics and practical wisdom. University of Birmingham Research Portal (University of Birmingham). 2 indexed citations
2.
Middleton, Mark R., Richard J. Knox, Emma Cattell, et al.. (2010). Quinone Oxidoreductase-2–Mediated Prodrug Cancer Therapy. Science Translational Medicine. 2(40). 40ra50–40ra50. 9 indexed citations
3.
Jaberipour, Mansooreh, Christopher P. Guise, Jane I. Grove, et al.. (2009). Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: Effects of combining beneficial single mutations. Biochemical Pharmacology. 79(2). 102–111. 27 indexed citations
4.
Knox, Richard J., et al.. (2008). Nitroreductase from Bacillus licheniformis: A stable enzyme for prodrug activation. Biochemical Pharmacology. 77(1). 21–29. 32 indexed citations
5.
Allen, O.R., Richard J. Knox, & Patrick C. McGowan. (2008). Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs. Dalton Transactions. 5293–5293. 19 indexed citations
6.
Plumb, Jane A., Alan Bilsland, Jiangqin Zhao, et al.. (2001). Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene. 20(53). 7797–7803. 82 indexed citations
7.
Bagshawe, Kenneth D., Philip J. Burke, Richard J. Knox, Roger G. Melton, & Surinder K. Sharma. (1999). Targeting enzymes to cancers - new developments. Expert Opinion on Investigational Drugs. 8(2). 161–172. 6 indexed citations
8.
Bagshawe, Kenneth D., Surinder K. Sharma, Philip J. Burke, Roger G. Melton, & Richard J. Knox. (1999). Developments with targeted enzymes in cancer therapy. Current Opinion in Immunology. 11(5). 579–583. 35 indexed citations
9.
Knox, Richard J., et al.. (1997). Prodrugs in cancer chemotherapy. Pathology & Oncology Research. 3(4). 309–324. 18 indexed citations
10.
Wu, Kebin, Richard J. Knox, Xiu Zhu Sun, et al.. (1997). Catalytic Properties of NAD(P)H:Quinone Oxidoreductase-2 (NQO2), a Dihydronicotinamide Riboside Dependent Oxidoreductase. Archives of Biochemistry and Biophysics. 347(2). 221–228. 116 indexed citations
11.
Knox, Richard J., Frank Friedlos, Michael Jarman, et al.. (1995). Virtual cofactors for an Escherichia coli nitroreductase enzyme: Relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT). Biochemical Pharmacology. 49(11). 1641–1647. 29 indexed citations
12.
Skelly, Jane V., et al.. (1994). Crystallization and Preliminary Crystallographic Data for an FMN-dependent Nitroreductase from Escherichia coli B. Journal of Molecular Biology. 238(5). 852–853. 8 indexed citations
13.
Knox, Richard J., et al.. (1992). The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II. Biochemical Pharmacology. 44(12). 2297–2301. 85 indexed citations
14.
Melton, Roger G., et al.. (1992). The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I. Biochemical Pharmacology. 44(12). 2289–2295. 183 indexed citations
15.
Knox, Richard J., Frank Friedlos, Tania Marchbank, & J. J. Roberts. (1991). Bioactivation of CB 1954: Reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species. Biochemical Pharmacology. 42(9). 1691–1697. 55 indexed citations
16.
17.
18.
Knox, Richard J., Frank Friedlos, David Lydall, & J. J. Roberts. (1986). Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.. PubMed. 46(4 Pt 2). 1972–9. 428 indexed citations
19.
Knox, Richard J., R.C. Knight, & David Edwards. (1983). Studies on the action of nitroimidazole drugs. Biochemical Pharmacology. 32(14). 2149–2156. 52 indexed citations
20.
Jaccard, James, Richard J. Knox, & David Brinberg. (1979). Prediction of behavior from beliefs: An extension and test of a subjective probability model.. Journal of Personality and Social Psychology. 37(7). 1239–1248.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Friedlos Breakdown of academic impact, for papers by Mary K. Danks Breakdown of academic impact, for papers by Athanassios Giannis Breakdown of academic impact, for papers by Roger M. Phillips Breakdown of academic impact, for papers by Jeffrey A. Dodge Breakdown of academic impact, for papers by Hirofumi Nakano Breakdown of academic impact, for papers by Rosanna Supino Breakdown of academic impact, for papers by Ze‐Hong Miao Breakdown of academic impact, for papers by Graham J. Atwell Breakdown of academic impact, for papers by Birandra K. Sinha
Rankless by CCL
2026